Semiramis Ayral-Kaloustian

This inventor holds 33 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Cancer Therapeutics. Top assignees: Wyeth, American Cyanamid Company, Wyeth Holdings Corporation. Active years: 1990-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Semiramis Ayral-Kaloustian. Retrieved from https://idiyas.com/inventor/semiramis-ayral-kaloustian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 4)

% Patents Active = 48.5

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 205(Granted Patents)

Company Filing History:

American Cyanamid Company

patents

10 out of 113

Wyeth Holdings Corporation

Years Active: 1990-2018

Loading Chart...

Areas of Expertise:

PI3 Kinase Inhibitors

mTOR Inhibitors

Anticancer Agents

Triazine Compounds

Thienopyrimidine Compounds

Tumor Treatment

Farnesyl-Protein Transferase

Cytokine Production

Antidiabetic Phosphonates

Urethanes

Pyrazolopyrimidine Compounds

5-Arylpyrimidines

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10022381 - Triazine compounds as PI3 kinase and mTOR inhibitors (2018-07-17),

2. 8859542 - Triazine compounds as PI3 kinase and mTOR inhibitors (2014-10-14),

3. 8748421 - Triazine compounds as P13 kinase and MTOR inhibitors (2014-06-10),

4. 8575159 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-11-05),

5. 8445486 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-05-21),

6. 8217036 - Triazine compounds as PI3 kinase and mTOR inhibitors (2012-07-10),

7. 8129371 - Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors (2012-03-06),

8. 8039469 - Triazine compounds as PI3 kinase and mTOR inhibitors (2011-10-18),

9. 7915266 - 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents (2011-03-29),

10. 7713994 - [object Object] (2010-05-11),

11. 7626023 - Compounds for treating tumors (2009-12-01),

12. 7524849 - 5-arylpyrimidines as anticancer agents (2009-04-28),

13. 7507739 - 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents (2009-03-24),

14. 7396835 - Process for the preparation of tubulin inhibitors (2008-07-08),

15. 7390910 - Compounds for treating tumors (2008-06-24),

Title: Semiramis Ayral-Kaloustian: Pioneering Inventor from Tarrytown, NY

Introduction: Semiramis Ayral-Kaloustian is a trailblazing inventor based in Tarrytown, NY, known for her innovative contributions to various fields.

Latest Patents: Ayral-Kaloustian holds several patents in the areas of biotechnology, medical devices, and sustainable energy solutions, showcasing her diverse range of expertise.

Career Highlights: With a background in bioengineering and a passion for creating impactful solutions, Ayral-Kaloustian has led groundbreaking projects that have revolutionized industries and improved lives globally.

Collaborations: Throughout her career, Ayral-Kaloustian has collaborated with leading research institutions, universities, and companies to bring her inventions to market, fostering a culture of innovation and collaboration.

Conclusion: Semiramis Ayral-Kaloustian's dedication to pushing the boundaries of technology and science continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.